这是一项双盲,安慰剂控制,随机抽取的戒断研究,对主要抑郁障碍的辅助布雷克西普拉维护治疗进行了辅助治疗

Roger S McIntyre1, Kripa Sundararajan2, Saloni Behl2

  • 1Brain and Cognition Discovery Foundation and University of Toronto, Toronto, ON, Canada.

Acta neuropsychiatrica
|October 17, 2024
PubMed
概括

与继续治疗相比,在抗抑郁药治疗 (ADT) 稳定后的大型抑郁症 (MDD) 患者中中止辅助布雷克斯皮普拉的复发率相似. 在这两组中,大约80%的患者没有复发.

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
197
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
109